Μετάβαση στο περιεχόμενο

ΕτικέταYescarta

Seattle Cancer Care Alliance One of Only 51 Centers Certified for CAR-T Therapy

    So far there are only two chimeric antigen receptor T-cell (CAR-T) therapies approved by the U.S.Food and Drug Administration (FDA). They are Novartis’ Kymriah (tisagenlecleucel) and Gilead Sciences’ Yescarta (axicabtagene ciloleucel). They have … Continue Reading Seattle Cancer Care Alliance One of Only 51 Centers Certified for CAR-T Therapy